Biology and preclinical models of colorectal cancer metastasis
Intestinal Research · 31.10.2026 · 24 (4) · 635-654
DOI: 10.5217/ir.2025.00315 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Intestinal Research, erschienen am 31.10.2026. Verfasst von Yoojeong Seo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiation Oncology, Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Die Arbeit nennt 210 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cancer Prevention and Research Institute of Texas, NIH HHS, American Association for Cancer Research.
Abstract (Originalsprache)
Metastatic colorectal cancer (mCRC) is the principal cause of CRC-related mortality, yet the biology of mCRC remains only partly understood and challenging to interrogate experimentally. Despite recent progress in mapping recurrent genetic and epigenetic alterations and treatment responses of mCRC, these efforts provide limited insight into how heterogeneous primary tumors breach tissue barriers, survive in circulation, and colonize distant organs. In this review, we summarize current experimental systems for studying mCRC, including genetically engineered mouse models, carcinogen-induced and transplant models, and patient-derived organoid and xenograft platforms, and discuss how each captures or fails to capture key steps of the metastatic cascade and organ-specific microenvironments. We highlight practical obstacles to longitudinal sampling and quantitative readouts of metastatic burden, as well as conceptual gaps in modeling immune and stromal influences. Finally, we outline how emerging approaches, including single-cell and spatial transcriptomics, and advances in longitudinal tracking of metastatic burden could be combined into an integrated framework that more faithfully links mechanistic insight to clinical behavior and ultimately to metastasis-specific therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Radiation Oncology, Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- Division of Radiation Oncology, Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jaeil@mdanderson.org.
- Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jaeil@mdanderson.org.
- Program in Genetics and Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jaeil@mdanderson.org.
Förderung
- Cancer Prevention and Research Institute of Texas
- NIH HHS
- American Association for Cancer Research
- National Institutes of Health
Zitieren
APA
Seo, Y., Jang, J., & Park, J. I. (2026). Biology and preclinical models of colorectal cancer metastasis. Intestinal Research, 24(4), 635-654. https://doi.org/10.5217/ir.2025.00315
Vancouver
Seo Y, Jang J, Park JI. Biology and preclinical models of colorectal cancer metastasis. Intestinal Research. 2026;24(4):635-654. doi:10.5217/ir.2025.00315
BibTeX
@article{Seo2026,
author = {Seo, Yoojeong and Jang, Jinho and Park, Jae-Il},
title = {Biology and preclinical models of colorectal cancer metastasis},
journal = {Intestinal Research},
year = {2026},
volume = {24},
number = {4},
pages = {635--654},
doi = {10.5217/ir.2025.00315}
}
EUVIMED